CHF5633

DB18696InvestigationalProtein Based Therapies

CHF5633 is a fully synthetic pulmonary surfactant preparation comprising DPPC (dipalmitoylphosphatidylcholine), POPG Na (palmitoyl‐oleoyl‐phosphatidylglycerol sodium), a synthetic SP-C analogue, and a synthetic SP-B analogue.

Mechanism: Pharmacologically active on Pulmonary surfactant-associated protein B and Surfactant protein C
Curator reviewed
Code names: CHF-5633

Resolves to

Targets

P07988SFTPBP11686SFTPC

What you can answer from here — as of October 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with CHF5633, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account